---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-26-054274"
form_type: "8-K"
ticker: "NUTX"
cik: "0001479681"
company_name: "Nutex Health Inc."
filed_at: "2026-08-06T20:04:00+00:00"
generated_at: "2026-08-06T20:05:18.721132+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Nutex Health Q2 net income $65.8M vs loss $17.7M YoY; revenue down 13.6%

## Summary
- Diluted EPS $9.38 vs $(2.95) in Q2 2025; six-month net income $112.6M, EPS $15.87.
- Revenue $210.8M (-13.6% YoY) due to prior-year IDR benefits; hospital visits +9.6%.
- Adjusted EBITDA $90.0M vs $71.6M; operating cash flow $34.2M vs $27.3M.
- HaloMD amendment and CMS fee cut reduced contract services by $52.3M; expects 25-30% ongoing savings.
- Cash $205.2M, long-term debt $31.1M; three new hospitals expected to open in H2 2026.

## SEC filing metadata
- accession: 0001628280-26-054274
- form_type: 8-K
- ticker: NUTX
- cik: 0001479681
- company_name: Nutex Health Inc.
- filed_at: 2026-08-06T20:04:00+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1479681/000162828026054274/0001628280-26-054274-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1479681/000162828026054274/nutx-20260806.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-26-054274
- JSON: https://secwatch.observer/filing/0001628280-26-054274.json
- Plain text: https://secwatch.observer/filing/0001628280-26-054274.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.